These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8658510)

  • 1. Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin.
    Moolgavkar SH; Luebeck EG; Buchmann A; Bock KW
    Toxicol Appl Pharmacol; 1996 May; 138(1):31-42. PubMed ID: 8658510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter.
    Conolly RB; Andersen ME
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):281-93. PubMed ID: 9344896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on initiation and promotion of GST-P-positive foci in rat liver: A quantitative analysis of experimental data using a stochastic model.
    Luebeck EG; Buchmann A; Stinchcombe S; Moolgavkar SH; Schwarz M
    Toxicol Appl Pharmacol; 2000 Aug; 167(1):63-73. PubMed ID: 10936080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 2,3,7,8-tetrachloro- and 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin on the proliferation of preneoplastic liver cells in the rat.
    Buchmann A; Stinchcombe S; Körner W; Hagenmaier H; Bock KW
    Carcinogenesis; 1994 Jun; 15(6):1143-50. PubMed ID: 8020147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats.
    Tritscher AM; Clark GC; Sewall C; Sills RC; Maronpot R; Lucier GW
    Carcinogenesis; 1995 Nov; 16(11):2807-11. PubMed ID: 7586202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walker NJ; Tritscher AM; Sills RC; Lucier GW; Portier CJ
    Toxicol Sci; 2000 Apr; 54(2):330-7. PubMed ID: 10774815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis.
    Lucier GW; Tritscher A; Goldsworthy T; Foley J; Clark G; Goldstein J; Maronpot R
    Cancer Res; 1991 Mar; 51(5):1391-7. PubMed ID: 1671757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine.
    Pitot HC; Goldsworthy T; Campbell HA; Poland A
    Cancer Res; 1980 Oct; 40(10):3616-20. PubMed ID: 6108157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of preneoplastic foci in rat liver with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin and a defined mixture of 49 polychlorinated dibenzo-p-dioxins.
    Schrenk D; Buchmann A; Dietz K; Lipp HP; Brunner H; Sirma H; Münzel P; Hagenmaier H; Gebhardt R; Bock KW
    Carcinogenesis; 1994 Mar; 15(3):509-15. PubMed ID: 8118936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD.
    Portier CJ; Sherman CD; Kohn M; Edler L; Kopp-Schneider A; Maronpot RM; Lucier G
    Toxicol Appl Pharmacol; 1996 May; 138(1):20-30. PubMed ID: 8658509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats.
    Teeguarden JG; Dragan YP; Singh J; Vaughan J; Xu YH; Goldsworthy T; Pitot HC
    Toxicol Sci; 1999 Oct; 51(2):211-23. PubMed ID: 10543023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin and 17beta-estradiol in male Sprague-Dawley rats.
    Wyde ME; Cambre T; Lebetkin M; Eldridge SR; Walker NJ
    Toxicol Sci; 2002 Aug; 68(2):295-303. PubMed ID: 12151625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of N-nitrosodiethylamine-initiated hepatocellular tumors and hepatoblastomas by 2,3,7,8-tetrachlorodibenzo-p-dioxin or Aroclor 1254 in C57BL/6, DBA/2, and B6D2F1 mice.
    Beebe LE; Fornwald LW; Diwan BA; Anver MR; Anderson LM
    Cancer Res; 1995 Nov; 55(21):4875-80. PubMed ID: 7585523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints.
    Maronpot RR; Foley JF; Takahashi K; Goldsworthy T; Clark G; Tritscher A; Portier C; Lucier G
    Environ Health Perspect; 1993 Dec; 101(7):634-42. PubMed ID: 8143597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating cell proliferation kinetics into models for cancer risk assessment.
    Moolgavkar SH; Luebeck EG
    Toxicology; 1995 Sep; 102(1-2):141-7. PubMed ID: 7482549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.
    Pitot HC; Goldsworthy TL; Moran S; Kennan W; Glauert HP; Maronpot RR; Campbell HA
    Carcinogenesis; 1987 Oct; 8(10):1491-9. PubMed ID: 2888545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat.
    Dragan YP; Xu XH; Goldsworthy TL; Campbell HA; Maronpot RR; Pitot HC
    Carcinogenesis; 1992 Aug; 13(8):1389-95. PubMed ID: 1354083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian tumors in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment.
    Davis BJ; Mccurdy EA; Miller BD; Lucier GW; Tritscher AM
    Cancer Res; 2000 Oct; 60(19):5414-9. PubMed ID: 11034082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of hepatic 8-oxo-deoxyguanosine adducts by 2,3,7,8-tetrachlorodibenzo-p-dioxin in Sprague-Dawley rats is female-specific and estrogen-dependent.
    Wyde ME; Wong VA; Kim AH; Lucier GW; Walker NJ
    Chem Res Toxicol; 2001 Jul; 14(7):849-55. PubMed ID: 11453731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.